These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31838720)

  • 1. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
    Ettcheto M; Cano A; Manzine PR; Busquets O; Verdaguer E; Castro-Torres RD; García ML; Beas-Zarate C; Olloquequi J; Auladell C; Folch J; Camins A
    Mol Neurobiol; 2020 Apr; 57(4):1814-1827. PubMed ID: 31838720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
    Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
    Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms.
    Du Y; Qu J; Zhang W; Bai M; Zhou Q; Zhang Z; Li Z; Miao J
    Neuropharmacology; 2016 Sep; 108():1-13. PubMed ID: 27067919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet induced discrepant peripheral and central nervous systems insulin resistance in APPswe/PS1dE9 and wild-type C57BL/6J mice.
    Guo Y; Ma X; Li P; Dong S; Huang X; Ren X; Yuan L
    Aging (Albany NY); 2020 Dec; 13(1):1236-1250. PubMed ID: 33291072
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
    Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
    J Biol Chem; 2019 Feb; 294(8):2714-2731. PubMed ID: 30563837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
    Bao J; Liu W; Zhou HY; Gui YR; Yang YH; Wu MJ; Xiao YF; Shang JT; Long GF; Shu XJ
    Curr Med Sci; 2020 Feb; 40(1):18-27. PubMed ID: 32166661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydroxy Stilbene Glucoside Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice.
    Gao D; Chen C; Huang R; Yang CC; Miao BB; Li L; Zhang L
    Curr Med Sci; 2021 Apr; 41(2):279-286. PubMed ID: 33877543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
    J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.
    Lee JW; Lee YK; Ban JO; Ha TY; Yun YP; Han SB; Oh KW; Hong JT
    J Nutr; 2009 Oct; 139(10):1987-93. PubMed ID: 19656855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice.
    Liu M; Chen F; Sha L; Wang S; Tao L; Yao L; He M; Yao Z; Liu H; Zhu Z; Zhang Z; Zheng Z; Sha X; Wei M
    Mol Neurobiol; 2014 Jun; 49(3):1350-63. PubMed ID: 24356899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
    Nan S; Wang P; Zhang Y; Fan J
    Drug Des Devel Ther; 2021; 15():2013-2024. PubMed ID: 34012254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response.
    Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B
    Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Z-Guggulsterone attenuates cognitive defects and decreases neuroinflammation in APPswe/PS1dE9 mice through inhibiting the TLR4 signaling pathway.
    Liu J; Lin Y; Yang Y; Guo Y; Shang Y; Zhou B; Liu T; Fan J; Wei C
    Biochem Pharmacol; 2022 Aug; 202():115149. PubMed ID: 35714682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice.
    Denver P; English A; McClean PL
    Brain Behav Immun; 2018 May; 70():423-434. PubMed ID: 29604345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.